Company intelligence / Profile preview
Shanghai Hengrui Pharmaceutical Co., Ltd.
Lianyungang, Jiangsu, Chinahengrui.com ↗
- Ownership
- Private
- Employees
- ~5600
- Development stage
- Commercial
01
Overview
Hengrui Pharma is one of China's largest pharmaceutical innovators, with 24 novel drugs and 4 other innovative drugs marketed, over 100 innovative candidates in development, and 400+ clinical trials globally. Lead programs include camrelizumab (anti-PD-1, marketed in China), rezvilutamide (AR inhibitor), apatinib (VEGFR2 inhibitor), and fluzoparib (PARP inhibitor), with strengths in oncology, immunology, metabolic, and cardiovascular diseases[3][2][8].
- Therapeutic areas
- ImmunologyEndocrinologyMetabolic DisordersOphthalmologyInfectious DiseasesDermatologyPulmonologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateProteolysis-targeting chimera therapyRadiopharmaceuticalPeptidesmRNA-based drugsProtein
- Industry
- Pharma
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Request access →03
Partnerships
GSKMerck
Beyond the preview
Go deeper on Shanghai Hengrui Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Hengrui Pharmaceutical Co., Ltd..